Superoxide dismutase 1 and 2 gene polymorphism in Turkish vitiligo patients

Vitiligo is an acquired disease of unknown etiology. Several theories have been proposed to understand the pathogenesis. The role of oxidative stress has been getting more important in recent years. One of the primary antioxidant enzymes in vitiligo is the superoxide dismutase (SOD). The aim of this...

Full description

Bibliographic Details
Main Authors: Tuna A, Ozturk G, Gerceker TB, Karaca E, Onay H, Guvenc SM, Cogulu O
Format: Article
Language:English
Published: Sciendo 2017-12-01
Series:Balkan Journal of Medical Genetics
Subjects:
Online Access:https://doi.org/10.1515/bjmg-2017-0033
_version_ 1797761216695762944
author Tuna A
Ozturk G
Gerceker TB
Karaca E
Onay H
Guvenc SM
Cogulu O
author_facet Tuna A
Ozturk G
Gerceker TB
Karaca E
Onay H
Guvenc SM
Cogulu O
author_sort Tuna A
collection DOAJ
description Vitiligo is an acquired disease of unknown etiology. Several theories have been proposed to understand the pathogenesis. The role of oxidative stress has been getting more important in recent years. One of the primary antioxidant enzymes in vitiligo is the superoxide dismutase (SOD). The aim of this study is to investigate the polymorphisms of the SOD1 and SOD2 in Turkish vitiligo patients. One hundred one vitiligo patients and 99 healthy controls without family history of vitiligo were included into the study. The SOD1 35 A/C and SOD2 A16V (C/T) polymorphisms were analyzed by polymerase chain reaction-restriction fragment length polymorphim (PCR-RFLP). Vitiligo patients and control group of SOD1 35 A/C and SOD2 A16V (C/T) polymorphism allele frequencies were compared by using χ2 tests. The distribution of the SOD1 35 AA and AC genotypes were similar in vitiligo patients and control group. When the patient and the control groups were compared for the SOD2 Ala9Val (C/T) polymorphism, a significant difference was determined for the distribution of the genotypes [p = 0.047, odds ratio (OR) = 2.075, 95% confidence interval (95% CI) = 1.008-4.272]. The relative risk for development of vitiligo was found as a 2-fold increase in the TT genotype. The increase of TT homozygosity in the vitiligo cases creates the problem on the transfer of the enzyme to the mitochondria and thus, the SODs antioxidant effect may decrease in vitiligo but the polymorphism was not determined in all patients, so this study needs to be substantiated by other studies containing a higher number of patients.
first_indexed 2024-03-12T19:09:45Z
format Article
id doaj.art-069636582f5c443c91e657eafa9e9594
institution Directory Open Access Journal
issn 1311-0160
language English
last_indexed 2024-03-12T19:09:45Z
publishDate 2017-12-01
publisher Sciendo
record_format Article
series Balkan Journal of Medical Genetics
spelling doaj.art-069636582f5c443c91e657eafa9e95942023-08-02T05:57:35ZengSciendoBalkan Journal of Medical Genetics1311-01602017-12-01202677310.1515/bjmg-2017-0033bjmg-2017-0033Superoxide dismutase 1 and 2 gene polymorphism in Turkish vitiligo patientsTuna A0Ozturk G1Gerceker TB2Karaca E3Onay H4Guvenc SM5Cogulu O6Department of Dermatology and Venerology, Faculty of Medicine, Ege University, Izmir, TurkeyDepartment of Dermatology and Venerology, Faculty of Medicine, Ege University, Izmir, TurkeyDepartment of Dermatology and Venerology, Faculty of Medicine, Ege University, Izmir, TurkeyDepartment of Genetics, Faculty of Medicine, Ege University, Izmir, TurkeyDepartment of Genetics, Faculty of Medicine, Ege University, Izmir, TurkeyDepartment of Genetics, Faculty of Medicine, Ege University, Izmir, TurkeyDepartment of Genetics, Faculty of Medicine, Ege University, Izmir, TurkeyVitiligo is an acquired disease of unknown etiology. Several theories have been proposed to understand the pathogenesis. The role of oxidative stress has been getting more important in recent years. One of the primary antioxidant enzymes in vitiligo is the superoxide dismutase (SOD). The aim of this study is to investigate the polymorphisms of the SOD1 and SOD2 in Turkish vitiligo patients. One hundred one vitiligo patients and 99 healthy controls without family history of vitiligo were included into the study. The SOD1 35 A/C and SOD2 A16V (C/T) polymorphisms were analyzed by polymerase chain reaction-restriction fragment length polymorphim (PCR-RFLP). Vitiligo patients and control group of SOD1 35 A/C and SOD2 A16V (C/T) polymorphism allele frequencies were compared by using χ2 tests. The distribution of the SOD1 35 AA and AC genotypes were similar in vitiligo patients and control group. When the patient and the control groups were compared for the SOD2 Ala9Val (C/T) polymorphism, a significant difference was determined for the distribution of the genotypes [p = 0.047, odds ratio (OR) = 2.075, 95% confidence interval (95% CI) = 1.008-4.272]. The relative risk for development of vitiligo was found as a 2-fold increase in the TT genotype. The increase of TT homozygosity in the vitiligo cases creates the problem on the transfer of the enzyme to the mitochondria and thus, the SODs antioxidant effect may decrease in vitiligo but the polymorphism was not determined in all patients, so this study needs to be substantiated by other studies containing a higher number of patients.https://doi.org/10.1515/bjmg-2017-0033sod1sod2superoxide dismutase (sod)vitiligo
spellingShingle Tuna A
Ozturk G
Gerceker TB
Karaca E
Onay H
Guvenc SM
Cogulu O
Superoxide dismutase 1 and 2 gene polymorphism in Turkish vitiligo patients
Balkan Journal of Medical Genetics
sod1
sod2
superoxide dismutase (sod)
vitiligo
title Superoxide dismutase 1 and 2 gene polymorphism in Turkish vitiligo patients
title_full Superoxide dismutase 1 and 2 gene polymorphism in Turkish vitiligo patients
title_fullStr Superoxide dismutase 1 and 2 gene polymorphism in Turkish vitiligo patients
title_full_unstemmed Superoxide dismutase 1 and 2 gene polymorphism in Turkish vitiligo patients
title_short Superoxide dismutase 1 and 2 gene polymorphism in Turkish vitiligo patients
title_sort superoxide dismutase 1 and 2 gene polymorphism in turkish vitiligo patients
topic sod1
sod2
superoxide dismutase (sod)
vitiligo
url https://doi.org/10.1515/bjmg-2017-0033
work_keys_str_mv AT tunaa superoxidedismutase1and2genepolymorphisminturkishvitiligopatients
AT ozturkg superoxidedismutase1and2genepolymorphisminturkishvitiligopatients
AT gercekertb superoxidedismutase1and2genepolymorphisminturkishvitiligopatients
AT karacae superoxidedismutase1and2genepolymorphisminturkishvitiligopatients
AT onayh superoxidedismutase1and2genepolymorphisminturkishvitiligopatients
AT guvencsm superoxidedismutase1and2genepolymorphisminturkishvitiligopatients
AT coguluo superoxidedismutase1and2genepolymorphisminturkishvitiligopatients